Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / GordonMD Global Investments LP
Form 13F · Q2 2026

GordonMD Global Investments LP

CIK 2039349Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$207M
Reported book value
16
Positions
3
Quarters on record
Top 50
Positions

GordonMD Global Investments LP — holdings

Top 16 positions of 16, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1KYTX Kyverna Therapeutics Inc4.2M+0.0%$38M18.3%
2PYXS Pyxis Oncology Inc10.0M+143.2%$30M14.6%
3TSHA Taysha Gene Therapies Inc723,185−1.9%$25M11.9%
4TEVA PHARMACEUTICAL INDS LTD Teva Pharmaceutical Inds Ltd2.4M+91.1%$16M7.9%
5VIR Vir Biotechnology Inc1.4M−10.9%$14M6.7%
6ALLO Allogene Therapeutics Inc5.3M+270.5%$11M5.3%
7CLDX Celldex Therapeutics Inc New279,720+64.2%$10M5.0%
8EDIT Editas Medicine Inc3.1M—$10M4.9%
9RARE Ultragenyx Pharmaceutical In289,101+0.0%$10M4.7%
10BLCO Bausch Plus Lomb Corp573,472+0.0%$9M4.6%
11AMGN Amgen Inc20,212+0.0%$7M3.5%
12SRRK Scholar Rock Hldg Corp132,500+0.0%$7M3.5%
13SION Sionna Therapeutics Inc136,000+0.0%$6M2.9%
14INCY Incyte Corp43,300+0.0%$5M2.4%
15CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In126,985+0.0%$5M2.3%
16INSM Insmed Inc28,587+0.0%$3M1.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.